newsfilter
← Latest News
GlobeNewswire·

Entasis Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

-Management to Host Conference Call on August 12 at 8am ET- Patient Enrollment in the ATTACK Phase 3 Registrational Trial Completed; Top-Line Data Readout Expected Early Fourth Quarter 2021 SUL-DUR Launch Planning Progresses with Appointment of Anna